EICHORCondition: Fibromyalgia · Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
The purpose of this study is to evaluate the efficacy and safety of a controlled release formulation of pregabalin administered once daily as compared to placebo in the treatment of fibromyalgia. All patients will receive pregabalin; half of the patients will receive placebo at some point in the study.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: * Patients must have fibromyalgia. Exclusion Criteria: * Patients with other painful conditions cannot participate.
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| Andrew O. Schreiber, MD | Orange, California, United States | — |
| Apex Research Institute | Santa Ana, California, United States | — |
| Paddock Park Clinical Research | Ocala, Florida, United States | — |
| Broward Research Group | Pembroke Pines, Florida, United States | — |
| Meridien Research | Tampa, Florida, United States | — |
| Arthritis Care Center | Moline, Illinois, United States | — |
| Davis Clinic, Inc | Indianapolis, Indiana, United States | — |
| Central Kentucky Research Associates, Inc. | Lexington, Kentucky, United States | — |
| Commonwealth Biomedical Research, LLC | Madisonville, Kentucky, United States | — |
| Boston Clinical Trials | Boston, Massachusetts, United States | — |
| Beacon Clinical Research, LLC | Brockton, Massachusetts, United States | — |
| The Center for Pharmaceutical Research, PC | Kansas City, Missouri, United States | — |
+ 40 more locations — full list on the registry record.
This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT01271933